P53 and PML: New partners in tumor suppression

Trends in Cell Biology

Volumn 11, Issue 5, 2001, Pages 184-187

  Gottifredi, Vanesa ^a   Prives, Carol ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL AGING; CELL DEATH; CELL DIFFERENTIATION; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REGULATORY MECHANISM; SENESCENCE;

EID: 0035341813     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(01)01983-3     Document Type: Review

References (55)

1. The complexity of p53 modulation: Emerging patterns from divergent signals
2. p53: Puzzle and paradigm
3. Regulation of p53 stability
4. p53, the cellular gatekeeper for growth and division
5. The transcriptional role of PML and the nuclear body
6. Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs
7. Transcriptional regulation of cellular transformation
8. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
9. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins
10. A role for PML and the nuclear body in genomic stability
11. PML induces a novel caspase-independent death process
12. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
13. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
14. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
15. Senescence of human fibroblasts induced by oncogenic Raf
16. PML is induced by oncogenic ras and promotes premature senescence
17. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
18. The function of PML in p53-dependent apoptosis
19. Regulation of p53 activity in nuclear bodies by a specific PML isoform
20. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
21. Protein regulation: Tag wrestling with relatives of ubiquitin
22. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localisation
23. Identification of three major sentrinization sites in PML
24. Role of SUMO-1-modified PML in nuclear body formation
25. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1
26. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis
27. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML
28. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
29. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
30. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
31. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
32. SUMO-1 modification activates the transcriptional response of p53
33. DNA damage activates p53 through a phosphorylation-acetylation cascade
34. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
35. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
36. Interaction of SP100 with HP1 proteins: A link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment
37. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
38. The p53 pathway
39. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
40. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation
41. Regulation of p53 function and stability by phosphorylation
42. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
43. Nucleolar Arf sequesters Mdm2 and activates p53
44. Identification of a cryptic nucleolar-localization signal in MDM2
45. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line
46. Transforming potential of the adenovirus type 5 E4orf3 protein
47. Nuclear domain 10, the site of DNA virus transcription and replication
48. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
49. PML nuclear bodies are general targets for inflammation and cell proliferation
50. HSV-1 IE protein Vmw110 causes redistribution of PML
51. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML
52. The regulation of E2F by pRB-family proteins
53. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
54. Escape from premature senescence is not sufficient for oncogenic transformation by Ras
55. Frequency of RAS and p53 mutations in acute promyelocytic leukemias